A Key Component of Human Augmentation, the Global Bionics Market will Reach $51 Billion by 2028
Speak directly to the analyst to clarify any post sales queries you may have.
Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.
In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.
Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.
This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.
Table of Contents
Companies Mentioned
- Abbott Laboratories
- AbbVie Inc.
- Abiomed
- Asahi Kasei Kuraray Medical Co. Ltd.
- Baxter International
- Bionic Power
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Ekso Bionics Holdings Inc.
- ExoAtlet
- LivaNova PLC
- Lockheed Martin Corporation
- Medtronic plc
- Orthofix Holdings Inc.
- Ossur Corporate
- Otto Bock HealthCare GmBH
- RB3D
- Sarcos Corporation
- Sonova Holding AG
- Spring Active
- SRI International
- SynCardia Systems LLC
- Zimmer Biomet Holdings
Methodology
LOADING...